RxDoctor Payments Data
★ My doctorsLook up a doctor →

Dennis Birenbaum

Hematology & Oncology · Dallas, TXNPI 1538119045

Payments from drug & device makers

$25,373in general payments, 2019–2025

Across 307 payments — averaging $82.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$16K
  • Amgen$3K
  • Novartis$2K
  • Incyte Corporation$553
  • Pfizer$533
  • Merck$348
  • plus $3K from 42 others

What the payments were for

  • Food & beverage$4,79574%
  • Education$69911%
  • Other$94815%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.2$16,109
Amgen13$3,120
Novartis55$1,660
Incyte Corporation22$553
Pfizer40$533
Merck20$348
Johnson & Johnson(2 entities)13$346
Eisai Inc.17$343
Gilead(2 entities)11$242
AstraZeneca10$172
E.r. Squibb & Sons, L.L.C.10$163
Takeda Pharmaceuticals U.S.A., Inc.7$153
Lexicon Pharmaceuticals, Inc.8$118
Dova Pharmaceuticals7$111
Taiho Oncology, Inc.7$108
EMD Serono, Inc.6$105
Astellas Pharma US Inc5$96
Acrotech Biopharma Inc.3$88
Octapharma USA, Inc.2$78
Genentech USA, Inc.4$75
Sun Pharmaceutical Industries Inc.3$68
Blueprint Medicines Corporation3$54
Pharmacyclics LLC, An Abbvie Company3$50
Sanofi3$50
Regeneron Healthcare Solutions, Inc.2$50
Foundation Medicine, Inc.2$45
AMAG Pharmaceuticals, Inc.2$39
Bristol Myers Squibb2$39
GSK2$36
Sirtex Medical Inc2$35
Exelixis Inc.2$34
Clovis Oncology, Inc.2$32
Array Biopharma Inc2$31
Ipsen Biopharmaceuticals, Inc1$26
Deciphera Pharmaceuticals Inc.1$25
Global Blood Therapeutics, Inc.1$25
Myovant Sciences Inc.1$24
Coherus Oncology, Inc.1$23
Acceleron Pharma, Inc.1$22
Advanced Accelerator Applications1$21
Bayer1$19
Karyopharm Therapeutics Inc.1$18
EUSA Pharma (US) LLC1$18
Alnylam Pharmaceuticals Inc.1$16
Helsinn Therapeutics (U.S.), Inc.1$15
Rigel Pharmaceuticals, Inc.1$15
Tactile Systems Technology Inc1$12
Epizyme, Inc.1$11

How this compares

$25,373 in reported general payments places this provider in the 60th percentile of 838 hematology & oncology providers in Texas.

See all hematology & oncology providers in Texas →

Other hematology & oncology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →